<PAGE> 1
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the registrant [X]
Filed by a party other than the registrant [ ]
Check the appropriate box:
[ ] Preliminary proxy statement [ ] Confidential, for Use of the Com-
mission Only (as permitted by
Rule 14a-6(e)(2))
[X] Definitive proxy statement
[ ] Definitive additional materials
[ ] Soliciting material pursuant to Rule 14a-11(c) or
Rule 14a-12
NEOGEN CORPORATION
- - -------------------------------------------------------------------------------
(Name of Registrant as Specified in Its Charter)
NEOGEN CORPORATION
- - -------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of filing fee (Check the appropriate box):
[X] $125 per Exchange Act Rule 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(i)(2)
or Item 22(a)(2) of Schedule 14A.
[ ] $500 per each party to the controversy pursuant to Exchange Act
Rule 14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
- - --------------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
- - --------------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):
- - --------------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
- - --------------------------------------------------------------------------------
(5) Total fee paid:
- - --------------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.
- - --------------------------------------------------------------------------------
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
(1) Amount previously paid:
- - --------------------------------------------------------------------------------
(2) Form, schedule or registration statement no.:
- - --------------------------------------------------------------------------------
(3) Filing party:
- - --------------------------------------------------------------------------------
(4) Date filed:
- - --------------------------------------------------------------------------------
<PAGE> 2
[NEOGEN(TM) CORPORATION) LOGO]
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO THE SHAREHOLDERS:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of Neogen
Corporation (the "Company"), a Michigan corporation, will be held on October 5,
1995 at 9:00 a.m., local time, at the University Club of Michigan State
University, 3435 Forest Road, East Lansing, MI 48823, for the following
purposes:
1. To elect nine directors to serve for the ensuing year and until their
successors are elected.
2. To ratify the appointment of BDO Seidman, LLP as independent auditors of the
Company for the fiscal year ending May 31, 1996.
3. To transact such other business as may properly come before the meeting or
any adjournment thereof.
The foregoing items of business are more fully described in the Proxy Statement
accompanying this Notice.
Only shareholders of record at the close of business August 7, 1995 are
entitled to notice of and to vote at the meeting.
All shareholders are cordially invited to attend the meeting in person.
However, to assure your representation at the meeting, you are urged to mark,
sign, date, and return the enclosed proxy card as promptly as possible in the
postpaid envelope enclosed for that purpose. Any shareholder attending the
meeting may vote in person even if he or she returned a proxy.
Sincerely,
G. Bruce Papesh
G. Bruce Papesh
Secretary
Lansing, Michigan
September 1, 1995
IMPORTANT: WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, YOU ARE REQUESTED TO
COMPLETE AND PROMPTLY RETURN THE ENCLOSED PROXY IN THE ENVELOPE
PROVIDED.
<PAGE> 3
[NEOGEN(TM) CORPORATION LOGO]
----------------
PROXY STATEMENT
The enclosed Proxy is solicited on behalf of Neogen Corporation (The "Company")
for use at the Annual Meeting of Shareholders to be held October 5, 1995, at
9:00 a.m., or at any adjournment thereof, for the purposes set forth herein and
in the accompanying Notice of Annual Meeting of Shareholders. The Annual
Meeting will be held at the University Club of Michigan State University, 3435
Forest Road, East Lansing, MI 48823. The Company's telephone number is (517)
372-9200.
These proxy solicitation materials were mailed on or about September 1, 1995,
together with the Company's 1995 Annual Report to Shareholders, to all
shareholders entitled to vote at the meeting.
INFORMATION CONCERNING SOLICITATION AND VOTING
REVOCABILITY OF PROXIES
Any proxy given pursuant to this solicitation may be revoked by the person
giving it at any time before its use by delivering to the Company, before the
meeting, a written notice of revocation or a duly executed proxy bearing a
later date or by attending the meeting and voting in person.
VOTING AND SOLICITATION
Every shareholder voting at the annual meeting has one vote for each share on
all matters. The Company's By-Laws do not provide for cumulative voting in the
election of directors. Shares represented by valid, executed and dated proxies
in the enclosed form will be voted if received in time for the meeting in
accordance with the instructions thereon. Unless your proxy is otherwise
marked, it will be voted FOR management's nominees for the board of directors,
and FOR ratification of the appointment of the Company's independent auditor.
A simple majority of the shares issued and outstanding as of August 7, 1995
(the "Record Date") must be present or represented at the Annual Meeting to
constitute a quorum. Approval for any item of business to be voted upon at the
Annual Meeting will require the affirmative vote of a majority of those shares
which are present or represented. Abstentions will have the same effect as
votes against approval.
The cost of soliciting proxies will be borne by the Company. The Company has
retained the services of American Stock Transfer & Trust to aid in the
solicitation of proxies. The company estimates that the cost of soliciting
proxies will be less than $1,000 including out-of-pocket expenses. The company
may reimburse brokerage firms and other persons representing beneficial owners
of shares for their expenses in forwarding solicitation material to such
beneficial owners. Proxies may also be solicited by certain of the Company's
directors, officers, and regular employees, without additional compensation,
personally or by telephone, telegram, facsimile or letter.
RECORD DATE AND PRINCIPAL SHARE OWNERSHIP
Shareholders of record at the close of business on August 7, 1995 are entitled
to notice of and to vote at the meeting. At the Record Date, 4,460,227 shares
of the Company's Common Stock were issued and outstanding. At the Record Date,
the following were known by the Company to be the beneficial owners of more
than 5% of the Company's Common Stock.
1
<PAGE> 4
<TABLE>
<CAPTION>
NUMBER PERCENT
NAME AND ADDRESS OF SHARES OF TOTAL
- - --------------------------------------------------------------------------------
<S> <C> <C>
Dart Container Corporation and Affiliates-RCD
Limited Partnership and KBD Limited Partnership
c/o First Interstate Bank of Nevada, N.A.
Trust Department
3800 Howard Hughes Parkway, Suite 200
Las Vegas, NV 89109................................ 389,675 8.7%
Herbert D. Doan(1)
P.O. Box 1431
Midland, MI 48641.................................. 296,223 6.6%
James L. Herbert(1)
Neogen Corporation
620 Lesher Place
Lansing, MI 48912.................................. 254,718 5.7%
</TABLE>
(1) Includes 13,334 shares and 34,000 shares of Common Stock which Mr.
Doan and Mr. Herbert, respectively, have the right to acquire by
exercise of options within 60 days of August 7, 1995.
DEADLINE FOR RECEIPT OF SHAREHOLDER PROPOSALS
Proposals of shareholders which are intended to be presented by such
shareholders at the Company's next Annual Meeting of Shareholders must be
received by the Company no later than May 3, 1996 in order that they may be
included in the proxy statement and form of proxy relating to that meeting.
PROPOSAL 1
ELECTION OF DIRECTORS
NOMINEES
A board of nine directors is to be elected at the meeting. Unless otherwise
instructed, the proxy holders will vote the proxies received by them for the
Company's nine nominees named below, eight of whom are presently directors of
the Company. In the event that any nominee of the Company is unable or
declines to serve as a director at the time of the Annual Meeting, the proxies
will be voted for any nominee who shall be designated by the present Board of
Directors to fill the vacancy. In the event that additional persons are
nominated for election as directors, the proxy holders intend to vote all
proxies received by them for nominees listed below. Shareholders may only vote
for nine directors. The Company is not aware of any nominee who will be unable
or will decline to serve as a director. The term of office of each person
elected as a director will continue until the next Annual Meeting of
Shareholders or until his successor has been elected and qualified.
The names of the nominees, and certain information about them, are set forth
below:
<TABLE>
<CAPTION>
NAME OF NOMINEE AGE POSITION DIRECTOR SINCE
- - -----------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
Herbert D. Doan(2)(3)......... 72 Chairman, Board of Directors 1982
James L. Herbert.............. 55 President and Chief Executive Officer of the Company, Director 1982
G. Bruce Papesh(1)............ 48 Secretary, Director 1993
Roland M. Hendrickson(2)...... 72 Director 1989
Gordon E. Guyer, Ph.D.(1)..... 69 Director 1990
Robert M. Book(3)............. 65 Director 1990
Leonard E. Heller, Ph.D.(3)... 50 Director 1992
Jack C. Parnell(2)............ 60 Director 1993
Thomas H. Reed................ 50 Director --
</TABLE>
2
<PAGE> 5
(1) Member, Audit Committee
(2) Member, Compensation Committee
(3) Member, Stock Option Committee
There are no family relationships among directors, nominees or executive
officers of the company. Information concerning nominees for the Board of
Directors follows:
Herbert D. Doan has been a director of the Company since September 1982 and the
Company's Chairman of the Board of Directors since October, 1984. He was
formerly President and Chief Executive Officer of Dow Chemical Company. He has
been active as an independent venture capitalist for the past five years.
James L. Herbert has been President, Chief Executive Officer, and a director of
the Company since he joined Neogen in June, 1982. He previously held the
position of Corporate Vice President of DeKalb Ag Research, a major
agricultural genetics and energy company. He has management experience in
animal biologics, specialized chemical research, medical instruments,
aquaculture, animal nutrition, and poultry and livestock breeding and
production.
Roland M. Hendrickson was elected to the Board of Directors in December, 1989.
He has served as President of Walt Montgomery Associates Inc., an international
consulting firm, since 1988. He was formerly a Vice President of Pfizer, Inc.,
a worldwide supplier of animal and human health products, and President of that
firm's agricultural division. Mr. Hendrickson also serves on the board of
directors of InnoVet Inc., a publicly traded biotechnology company engaged in
developing and marketing pharmaceutical and biological products for the human
health, animal health and agricultural markets.
Dr. Gordon E. Guyer joined the Board of Directors in January, 1990. Dr. Guyer
is currently serving as director for the Michigan Department of Agriculture, a
position he accepted in 1993. Prior to his current position, Dr. Guyer served
as interim President of Michigan State University where he held the position of
Vice President of Governmental Affairs since 1988. From 1986 to 1988, he was
Director of the Department of Natural Resources for the State of Michigan.
Robert M. Book was elected to the Board of Directors in November, 1990. Since
January, 1993, Mr. Book has served as President of AgriVista, Inc. a company
that provides agricultural consulting and marketing services. He served as
President of the Indiana Institute of Agriculture, Food and Nutrition, from
1983 through 1992. He was formerly Group Vice President of Agriculture
Marketing for Elanco Products Company. In January, 1992, Mr. Book filed a
petition for relief under Chapter 11 of the Bankruptcy Code in the United
States Bankruptcy Court, Southern District of Indiana, Indianapolis Division.
This petition was discharged on February 24, 1994. The Company believes that
the filing of this petition has had no effect on Mr. Book's ability to serve as
director.
Dr. Leonard E. Heller was elected to the Board of Directors in October, 1992.
He is currently a self-employed independent consultant in the area of medical,
biomedical, and pharmaceutical information systems. From 1992 to 1993, he was
Secretary, Cabinet for Human Resources for the Commonwealth of Kentucky. From
1986 to 1993 he was part owner of O.J. Packaging Inc., a retail packaging
company, and a general partner in Illinois Diversatech, a real estate
development partnership located in Manteno, Illinois. Dr. Heller owned 55% of
ELISA Technologies (formerly WTT, Inc.), a Kentucky-based company which sold
immunoassay diagnostics for agricultural and research markets. In September,
1992, Neogen acquired substantially all of the assets of ELISA Technologies.
The purchase price consisted of cash, assumption of certain liabilities, and
stock resulting in total consideration of approximately $1,120,000. It is
estimated that Dr. Heller's share of this transaction, after deducting
liabilities of ELISA Technologies not assumed by the Company, was approximately
$313,000 in cash and 42,767 shares of the Company's Common Stock. Since Dr.
Heller was not a member of the Board of Directors in September, 1992, the
Company believes this was an arm's length transaction.
G. Bruce Papesh was elected to the Board of Directors in October, 1993 and was
elected Secretary in October, 1994. Mr. Papesh is co-founder of Dart, Papesh &
Co., a Lansing, Michigan based company that provides investment consulting and
other financial services. He has served as President of Dart, Papesh & Co.
Inc, since 1987. Mr. Papesh is a graduate of the University of Notre Dame and
has over 25 years of experience in investment services while serving in stock
broker, consulting and executive management positions. Mr. Papesh provides
investment services to Dart Container Corporation and its affiliates which, on
a combined basis, own 8.7% of the Company's Common Stock.
Jack C. Parnell was elected to the Board of Directors in October, 1993. Since
1991, he has held the position of Governmental Relations Advisor with the law
firm of Kahn, Soares and Conway. In 1989, Mr. Parnell was appointed by
President Bush to serve as Deputy Secretary for the U.S. Department of
Agriculture. From 1983 to 1989, he served in three different senior
governmental positions for the State of California, including Secretary for the
California Department of Food and Agriculture from 1987 to 1989. Prior to
joining government, Mr. Parnell was a private entrepreneur owning and operating
various businesses including diversified cattle and farming operations. The
firm of Kahn, Soares and Conway currently acts as the Company's government
relation advisor.
3
<PAGE> 6
Thomas H. Reed is being nominated for election to the Board of Directors for
the first time. He currently serves as President and Chief Executive Officer
for the Michigan Livestock Exchange where he has worked since 1977. Mr. Reed
is a member of the Board of Directors of City Bank, St. Johns, Michigan and is
a former chairman of the Michigan State University Board of Trustees. He has
served as an officer or director of numerous trade organizations and financial
institutions.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE NOMINEES HEREIN.
SECURITY OWNERSHIP OF MANAGEMENT
The following table sets forth the beneficial ownership of Common Stock of the
Company as of August 7, 1995 for each current director, nominee and for all
current and executive officers as a group:
<TABLE>
<CAPTION>
NAME NUMBER OF SHARES PERCENT OF TOTAL
- - -----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
Herbert D. Doan(1) 296,223 6.6%
James L. Herbert(1) 254,718 5.7%
Roland M. Hendrickson(1) 12,667 *
Gordon E. Guyer, Ph.D.(1) 12,667 *
Robert M. Book(1) 12,001 *
Leonard E. Heller, Ph.D.(1) 50,768 1.7%
G. Bruce Papesh(1) 4,001 *
Jack C. Parnell(1) 4,001 *
Thomas H. Reed -- *
All current directors and executive officers as a group
(fifteen persons)(1) 813,931 17.6%
</TABLE>
* Less than 1%
(1) Includes the following shares of Common Stock which current directors and
executive officers have the right to acquire by exercise of options within
60 days of August 7, 1995: Mr. Doan-13,334 shares; Mr. Herbert-34,000
shares; Mr. Hendrickson-11,667 shares; Dr. Guyer-12,667 shares; Mr.
Book-12,001 shares; Dr. Heller-8,001 shares; Mr. Papesh-4,001 shares; Mr.
Parnell-4,001 shares; all current directors and executive officers as a
group-157,672 shares.
BOARD MEETINGS AND COMMITTEES
The Board of Directors of the Company held six meetings during the fiscal year
ended May 31, 1995. Each of the incumbent directors attended at least 75% of
the aggregate of all meetings of the Board and Committees of which he was a
member held during the period he served on the Board or Committee.
The standing committees of the Board of Directors are the Audit Committee, the
Compensation Committee and the Stock Option Committee. The Audit Committee,
which met two times in 1995, has responsibility for recommending to the Board
of Directors the firm of independent auditors to be retained by the Company;
reviewing with the Company's independent auditors the scope and results of
their audits; reviewing with the independent auditors and management the
Company's accounting and reporting principles, policies and practices; and
reviewing with the Company's independent auditors the adequacy of the Company's
accounting, financial and operating controls. The Compensation Committee,
which met one time during 1995, has responsibility for reviewing and approving
the Company's executive compensation policies and makes recommendations
concerning the Company's employee benefit programs. The Stock Option Commitee
administers the Company's Stock Option Plan. This committee held three
meetings during 1995 primarily to review and approve stock options granted
pursuant to the Plan.
The Board of Directors serves as a committee of the whole for purposes of
recommending candidates for election to the Board of Directors. In this
capacity, the Board held two meetings in fiscal year 1995. The Board will
consider nominees recommended by shareholders. Any shareholder may make such a
recommendation by writing to: Corporate Secretary, Neogen Corporation, 620
Lesher Place, Lansing, Michigan 48912.
EXECUTIVE COMPENSATION
The following table sets forth information regarding compensation paid or
accrued by the Company during the last three years for the Company's chief
executive officer, the only executive officer of the Company receiving annual
cash compensation in excess of $100,000.
4
<PAGE> 7
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
FISCAL OPTIONS ALL OTHER
NAME AND PRINCIPAL POSITION YEAR SALARY(1) BONUS AWARDED COMPENSATION(2)(3)
- - -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
James L. Herbert 1995 $126,165 $10,000 25,000 $1,436
President, Chief 1994 $137,936 $15,000 15,000 $640
Executive Officer 1993 $117,305 $15,000 15,000 $1,062
</TABLE>
(1) Includes amounts contributed to the Company's 401(k) Retirement Savings
Plan by the named executive officer.
(2) Matching contributions paid to the Company's 401(k) Retirement Savings
Plan on behalf of the named executive officer.
(3) Under terms of a deferred compensation agreement, the current value of an
annuity owned by the company is payable to the named executive officer
upon death, retirement or termination of employment.
The following table contains information concerning the grant of options under
the Company's Stock Option Plan to the named executive officer of the Company
during the year ended May 31, 1995. No stock appreciation rights (SARS) were
granted during such period.
OPTION GRANTS IN LAST FISCAL YEAR
INDIVIDUAL GRANTS
<TABLE>
<CAPTION>
PERCENT OF TOTAL
OPTIONS GRANTED
TO EMPLOYEES EXERCISE PRICE EXPIRATION
NAME GRANTED IN FISCAL YEAR PER SHARE DATE
- - --------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
James L. Herbert 25,000(1) 21.008% $7.25 6/6/99
</TABLE>
(1) Options were granted at fair market value and vest over five years in
equal annual installments commencing with the first anniversary of the
date grant.
The following table sets forth information for the named executive officer with
respect to the value of options exercised during the year ended May 31, 1995
and the value of outstanding and unexercised options held as of May 31, 1995,
based upon the market value of the Company's Common Stock of $7.000 per share
on that date. There were no SARS outstanding or exercised as of or for the
year ended May 31, 1995.
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL
YEAR-END OPTION VALUES
<TABLE>
<CAPTION>
NUMBER OF UNEXERCISED VALUE OF UNEXERCISED
OPTIONS IN-THE-MONEY OPTIONS
SHARES AT MAY 31, 1995 AT MAY 31, 1995(2)
ACQUIRED VALUE ------------------------------ ----------------------------
NAME ON EXERCISE REALIZED(1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
- - ---------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
James L. Herbert 2,625 $17,863 19,000 54,000 $78,180 $118,970
</TABLE>
(1) Represents the difference between the market price of the Common Stock
and the exercise price of the options on the date of exercise
multiplied by the number of shares acquired upon exercise.
(2) Represents the difference between the closing market price of the
Common Stock at May 31, 1995 of $7.000 per share and the exercise
price per share of in-the-money options multiplied by the number of
shares which could be acquired at May 31, 1995 upon the exercise of
all in-the-money options.
COMPENSATION OF DIRECTORS
The Company does not pay director's fees to any director for attendance at
meetings of the Board or Standing Committees. All non-employee directors
receive automatic, non-qualified options to purchase 5,000 shares of Common
Stock of the Company when first
5
<PAGE> 8
elected to the Board of Directors and non-qualified options to purchase 2,000
shares of Common Stock of the Company upon subsequent annual election to the
Board of Directors. The options expire ten years after the date of grant and
vest over three years in equal annual installments commencing with the first
anniversary of the date of grant. All directors are eligible to receive
reimbursement for all ordinary travel expenses related to attendance at Board
or committee meetings.
COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT OF 1934
Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
directors and executive officers, and persons who own more than ten percent of
a registered class of the Company's equity securities, to file with the
Securities and Exchange Commission ("SEC") initial reports of ownership and
reports of changes in ownership of Common Stock and other equity securities of
the Company. Officers, directors and greater than ten-percent shareholders are
required by SEC regulation to furnish the Company with copies of all Section
16(a) forms they file.
To the Company's knowledge, based solely on review of the copies of such
reports furnished to the Company and written representations that no other
reports were required, during the two fiscal years ended May 31, 1995 and May
31, 1994 all Section 16(a) filing requirements applicable to its officers,
directors and greater than ten percent beneficial owners were complied with;
except that one report covering one transaction, was filed late by Gerald S.
Traynor, a Company Vice President. As of the date hereof, Mr. Traynor has not
failed to file a required report.
PROPOSAL 2
APPOINTMENT OF INDEPENDENT AUDITOR
It is proposed that the shareholders ratify the appointment of BDO Seidman, LLP
as independent auditors of the Company for the year ending May 31, 1996. In
April, 1994, the Audit Committee of Neogen Corporation (the "Company) approved
and recommended to the Board of Directors and the Board of Directors approved
that the firm of BDO Seidman be selected as the Company's independent auditors
for the year ended May 31, 1994. BDO Seidman, LLP also served as the Company's
independent auditors for the fiscal year ended May 31, 1995. The firm of Ernst
& Young served as the Company's independent auditors for the fiscal year ended
May 31, 1993. Representatives of BDO Seidman, LLP are expected to be present
at the meeting with the opportunity to make a statement if they desire to do so
and are expected to be available to respond to appropriate questions.
The company believes there were no disagreements with Ernst & Young within the
meaning of Instruction 4 of Item 304 of Regulation S-B on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure in connection with the audits of the Company's 1992 or 1993
financial statements, or for any subsequent interim period, which disagreements
if not resolved to their satisfaction would have caused Ernst & Young to issue
an adverse opinion or a disclaimer of opinion, and neither report contained an
adverse opinion or disclaimer of opinion or was qualified or modified as to
uncertainty, audit scope, or accounting principles.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE RATIFICATION OF THE
APPOINTMENT OF BDO SEIDMAN, LLP AS INDEPENDENT AUDITORS.
NEOGEN CORPORATION WILL FURNISH A COPY OF ITS ANNUAL REPORT ON FORM 10-KSB FOR
THE YEAR ENDED MAY 31, 1995, WITHOUT EXHIBITS, WITHOUT CHARGE TO EACH PERSON
WHO FORWARDS A WRITTEN REQUEST INCLUDING REPRESENTATION THAT HE/SHE WAS A
SHAREHOLDER ON AUGUST 7, 1995 TO: CORPORATE SECRETARY, NEOGEN CORPORATION, 620
LESHER PLACE, LANSING, MICHIGAN 48912.
By Order of the Board of Directors
G. Bruce Papesh
G. Bruce Papesh
Secretary
Dated: September 1, 1995
6
<PAGE> 9
PROXY - NEOGEN CORPORATION
ANNUAL MEETING OF SHAREHOLDERS - OCTOBER 5, 1995
The undersigned hereby appoints G. Bruce Papesh and James L. Herbert,
and each of them with full power to appoint his substitute, attorneys and
proxies to represent the shareholder and to vote and act with respect to all
shares that the shareholder would be entitled to vote on all matters which come
before the annual meeting of shareholders of Neogen Corporation referred to
above and at any adjournment of that meeting.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.
(CONTINUED AND TO BE SIGNED ON THE REVERSE SIDE.)
SEE REVERSE
SIDE
PLEASE MARK YOUR
/X/ VOTES AS IN THIS
EXAMPLE.
<TABLE>
<S><C>
NOMINEES: Herbert D. Doan, James L. Herbert,
G. Bruce Papesh,
FOR WITHHELD Roland M. Hendrickson, FOR AGAINST ABSTAIN
1. ELECTION OF / / / / Gordon E. Guyer, Robert M. Book, 2. To ratify the appointment / / / / / /
DIRECTORS Leonard E. Heller, Jack C. Parnell, of BDO Seidman, LLP
and Thomas H. Reed as Independent Auditors of
the Company for the fiscal
year ending May 31, 1996.
For, except vote withheld from the following nominee(s):
_____________________________________________________________
</TABLE>
SIGNATURE(S)________________________________________________ DATE_________, 1995
NOTE: Please sign exactly as your name appears on this proxy. If signed for
estates, trusts, or corporations, title or capacity should be stated. If
shares are held jointly, each holder should sign.
